HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Amanda Olson Selected Research
Amanda Olson Research Topics
Disease
7
Hematologic Neoplasms (Hematological Malignancy)
12/2021 - 12/2014
6
Graft vs Host Disease (Graft-Versus-Host Disease)
02/2024 - 01/2018
6
Neoplasms (Cancer)
01/2022 - 09/2008
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 02/2017
3
Leukemia
01/2024 - 01/2022
3
COVID-19
12/2021 - 01/2021
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 12/2019
2
Infections
01/2024 - 02/2017
2
Virus Diseases (Viral Diseases)
01/2024 - 07/2015
2
Common Cold
03/2021 - 01/2021
2
Hemorrhagic Cystitis
01/2021 - 02/2017
2
Primary Myelofibrosis (Myelosclerosis)
01/2021 - 01/2020
1
Substance-Related Disorders (Drug Abuse)
11/2023
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2023
1
Myeloid Leukemia (Leukemia, Myelocytic)
10/2023
1
Chronic Disease (Chronic Diseases)
10/2023
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Cytokine Release Syndrome
01/2021
1
Hemorrhage
01/2021
1
cell-associated neurotoxicity
01/2021
1
Multiple Myeloma
10/2020
1
Lymphoma (Lymphomas)
01/2019
1
Acquired Immunodeficiency Syndrome (AIDS)
10/2018
1
Progressive Multifocal Leukoencephalopathy
10/2018
1
Disease Progression
01/2018
1
Bronchiolitis Obliterans Syndrome
06/2017
1
Pathologic Constriction (Stenosis)
02/2017
1
Residual Neoplasm
02/2017
1
Hodgkin Disease (Hodgkin's Disease)
01/2016
1
Human Influenza (Influenza)
07/2015
1
Pain (Aches)
09/2011
1
Nausea
09/2011
1
Melanoma (Melanoma, Malignant)
09/2008
1
Hypotension (Low Blood Pressure)
06/2007
Drug/Important Bio-Agent (IBA)
4
Busulfan (Busulfex)
FDA Link
01/2022 - 02/2017
4
fludarabine
IBA
01/2022 - 01/2019
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
02/2024 - 12/2021
2
Clofarabine (Clolar)
FDA Link
01/2022 - 02/2017
2
Steroids
IBA
01/2022 - 01/2021
2
Antibodies
IBA
03/2021 - 01/2021
2
Immunoglobulin G (IgG)
IBA
03/2021 - 01/2021
2
Chimeric Antigen Receptors
IBA
01/2021 - 10/2020
2
Enzymes
IBA
11/2018 - 05/2015
2
Fucosyltransferases
IBA
11/2018 - 05/2015
2
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2018 - 07/2015
1
Dronabinol (THC)
FDA Link
Generic
11/2023
1
Vorinostat
FDA Link
01/2022
1
blinatumomab
IBA
01/2022
1
Tacrolimus (Prograf)
FDA Link
Generic
12/2021
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
12/2021
1
eltrombopag
FDA Link
01/2021
1
vedolizumab
IBA
01/2021
1
Cytokines
IBA
01/2021
1
FM 100 (FM100)
IBA
01/2019
1
Melphalan (Alkeran)
FDA Link
Generic
01/2019
1
Proteins (Proteins, Gene)
FDA Link
10/2018
1
ruxolitinib
IBA
10/2018
1
HLA-DPB1 antigen (HLA DPB1)
IBA
01/2018
1
Antigens
IBA
07/2015
1
Guanosine Diphosphate Fucose (GDP Fucose)
IBA
05/2015
1
Misoprostol (Cytotec)
FDA Link
Generic
09/2011
1
Polymers
IBA
09/2008
1
veliparib
IBA
09/2008
1
Adenosine Diphosphate Ribose (ADP-Ribose)
IBA
09/2008
1
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
06/2007
1
pyridine
IBA
06/2007
1
Indazoles
IBA
06/2007
Therapy/Procedure
12
Transplantation
10/2023 - 12/2014
10
Hematopoietic Stem Cell Transplantation
02/2024 - 12/2014
5
Therapeutics
01/2024 - 05/2015
4
Stem Cell Transplantation
01/2024 - 01/2019
3
Cell Transplantation
01/2022 - 01/2021
2
Immunotherapy
01/2021 - 10/2020
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2024
1
Haploidentical Transplantation
12/2019
1
Homologous Transplantation
01/2019
1
Length of Stay
02/2017
1
Surgical Instruments (Clip)
09/2011